Impact of genotypic susceptibility score on cART outcomes during primary HIV infection

Andrea Giacomelli, Massimiliano Fabbiani, Ilaria De Benedetto, Silvia Nozza, Emanuele Focà, Benedetto M Celesia, Giulia Marchetti, Cristina Mussini, Andrea Antinori, Gabriella d'Ettorre, Giordano Madeddu, Alessandra Bandera, Antonio Muscatello, Stefano Rusconi

Research output: Contribution to journalArticle

Abstract

To assess the impact of genotypic susceptibility score (GSS) on combined antiretroviral therapy (cART) outcomes during primary HIV infection (PHI) we retrospectively enrolled patients with PHI diagnosed between 2008 and 2015 at 9/24 Italian Network ACuTe HIV InfectiON centers. One hundred-seventy-six patients were enrolled. Of these, 55 (32.9%) patients started with more than three drugs and 11 (7.2%) started with a GSS 
Original languageEnglish
Pages (from-to)1891-1895
Number of pages5
JournalJournal of Medical Virology
Volume91
Issue number10
DOIs
Publication statusPublished - Oct 2019

    Fingerprint

Keywords

  • GSS
  • HIV
  • primary HIV

Cite this

Giacomelli, A., Fabbiani, M., De Benedetto, I., Nozza, S., Focà, E., Celesia, B. M., Marchetti, G., Mussini, C., Antinori, A., d'Ettorre, G., Madeddu, G., Bandera, A., Muscatello, A., & Rusconi, S. (2019). Impact of genotypic susceptibility score on cART outcomes during primary HIV infection. Journal of Medical Virology, 91(10), 1891-1895. https://doi.org/10.1002/jmv.25517